CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company focused on bringing transformative therapies to patients with rare diseases, will report fourth quarter and full year 2015 financial results after the NASDAQ Global Market close on Wednesday, March 2, 2016. Jill C. Milne, Chief Executive Officer, and Ian Sanderson, Chief Financial Officer, will host a conference call and webcast at 4:30pm ET to provide an update on corporate developments and to discuss fourth quarter and last year’s financial results.
